Abstract
Cardiovascular disease (CVD) is the leading cause of mortality worldwide and hypertension is one of the main cardiovascular risk factors. A large body of evidence have demonstrated the increased risk for CVD and mortality associated with uncontrolled hypertension and also the benefits of an adequate blood pressure (BP) control. In some cases, lack of adherence to treatment found during the evaluation of a subject with poor BP control may be part of a more complex scenario, as depression. It is known that individuals with depression have a higher risk of CVD-related morbidity and mortality, and early diagnosis and treatment have beneficial effects.
Keywords: Blood pressure, cardiovascular disease, cardiovascular risk, depression, depressive disorder, hypertension, uncontrolled hypertension.
Current Hypertension Reviews
Title:Depression and its Relation with Uncontrolled Hypertension and Increased Cardiovascular Risk
Volume: 10 Issue: 1
Author(s): Erlon Oliveira de Abreu-Silva and Alexandre Baggio Todeschini
Affiliation:
Keywords: Blood pressure, cardiovascular disease, cardiovascular risk, depression, depressive disorder, hypertension, uncontrolled hypertension.
Abstract: Cardiovascular disease (CVD) is the leading cause of mortality worldwide and hypertension is one of the main cardiovascular risk factors. A large body of evidence have demonstrated the increased risk for CVD and mortality associated with uncontrolled hypertension and also the benefits of an adequate blood pressure (BP) control. In some cases, lack of adherence to treatment found during the evaluation of a subject with poor BP control may be part of a more complex scenario, as depression. It is known that individuals with depression have a higher risk of CVD-related morbidity and mortality, and early diagnosis and treatment have beneficial effects.
Export Options
About this article
Cite this article as:
Abreu-Silva Oliveira de Erlon and Todeschini Baggio Alexandre, Depression and its Relation with Uncontrolled Hypertension and Increased Cardiovascular Risk, Current Hypertension Reviews 2014; 10 (1) . https://dx.doi.org/10.2174/157340211001141111144533
DOI https://dx.doi.org/10.2174/157340211001141111144533 |
Print ISSN 1573-4021 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6506 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Scleroderma Subsetting
Current Rheumatology Reviews A Review on Phytochemistry and Pharmacology of Medicinal as well as Poisonous Mushrooms
Mini-Reviews in Medicinal Chemistry Virus Vasculopathy and Stroke: An Under-Recognized Cause and Treatment Target
Infectious Disorders - Drug Targets Novel Strategies in the Treatment of Pulmonary Arterial Hypertension
Current Drug Targets Recreational Use, Analysis and Toxicity of Tryptamines
Current Neuropharmacology Healthy Properties of Garlic
Current Nutrition & Food Science Structure-based Drugs Design Studies on Spleen Tyrosine Kinase Inhibitors
Letters in Drug Design & Discovery Involvement of Leukotriene Pathway in the Pathogenesis of Ischemia- Reperfusion Injury and Septic and Non-Septic Shock
Current Vascular Pharmacology Fat Digestion and its Role in Appetite Regulation and Energy Balance -The Importance of Enterostatin and Tetrahydrolipstatin
Current Medicinal Chemistry - Central Nervous System Agents A Study of Metabolic Parameters in Patients with Gout: A Single Center Study from Nepal
Endocrine, Metabolic & Immune Disorders - Drug Targets Multiple Drug Intolerance Syndrome: An Underreported Distinct Clinical Entity
Current Clinical Pharmacology Exploring Genetic Influences on Cognition: Emerging Strategies for Target Validation and Treatment Optimization
Current Drug Targets - CNS & Neurological Disorders MCM-41-SO3H as an Advanced Nanocatalyst for the Solvent-Free Synthesis of N-aryl-2-amino-1,6-naphthyridine Derivatives
Current Nanoscience Non Smoking for Successful Aging: Therapeutic Perspectives
Current Pharmaceutical Design ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke
Current Neuropharmacology Effect of Androgenic and Antiandrogenic Acting Compounds in Macrophage Accumulation and Cell Replication in the Aorta of Oophorectomized Hypercholesterolemic Rabbits
Vascular Disease Prevention (Discontinued) Review of the Relationship between Renal and Retinal Microangiopathy in Diabetes Mellitus Patients
Current Diabetes Reviews Cardiac Gene Therapy: Therapeutic Potential and Current Progress
Current Gene Therapy The Impact of Pharmaceutical Care Practice on the Practitioner and the Patient in the Ambulatory Practice Setting: Twenty-five Years of Experience
Current Pharmaceutical Design Aquaporin and Vascular Diseases
Current Neuropharmacology